Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Rebecca E. Glover"'
Autor:
Mark Petticrew, Rebecca E. Glover, Jimmy Volmink, Laurence Blanchard, Éadaoin Cott, Cécile Knai, Nason Maani, James Thomas, Alice Tompson, May C. I. van Schalkwyk, Vivian Welch
Publikováno v:
Systematic Reviews, Vol 12, Iss 1, Pp 1-14 (2023)
Abstract Background The field of the commercial determinants of health (CDOH) refers to the commercial products, pathways and practices that may affect health. The field is growing rapidly, as evidenced by the WHO programme on the economic and commer
Externí odkaz:
https://doaj.org/article/6657920d9164419da650a0ae4c31743e
Publikováno v:
The Lancet Microbe, Vol 2, Iss 11, Pp e637-e644 (2021)
Summary: Antibiotic research and development is at an inflection point. Faced with ongoing problems with commercial innovation, we argue for a networked public approach to support and coordinate existing research and development initiatives by sustai
Externí odkaz:
https://doaj.org/article/aacf5652e8a54576992a5c2ec4b50189
Autor:
Gwenan M. Knight, Nicholas G. Davies, Caroline Colijn, Francesc Coll, Tjibbe Donker, Danna R. Gifford, Rebecca E. Glover, Mark Jit, Elizabeth Klemm, Sonja Lehtinen, Jodi A. Lindsay, Marc Lipsitch, Martin J. Llewelyn, Ana L. P. Mateus, Julie V. Robotham, Mike Sharland, Dov Stekel, Laith Yakob, Katherine E. Atkins
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Antibiotics remain the cornerstone of modern medicine. Yet there exists an inherent dilemma in their use: we are able to prevent harm by administering antibiotic treatment as necessary to both humans and animals, but we must be mi
Externí odkaz:
https://doaj.org/article/d28eeb4aec5a465e8f6ad8ee4343de81
Autor:
Gwenan M Knight, Rebecca E Glover, C Finn McQuaid, Ioana D Olaru, Karin Gallandat, Quentin J Leclerc, Naomi M Fuller, Sam J Willcocks, Rumina Hasan, Esther van Kleef, Clare IR Chandler
Publikováno v:
eLife, Vol 10 (2021)
Before the coronavirus 2019 (COVID-19) pandemic began, antimicrobial resistance (AMR) was among the top priorities for global public health. Already a complex challenge, AMR now needs to be addressed in a changing healthcare landscape. Here, we analy
Externí odkaz:
https://doaj.org/article/a0c482ba9d674074885c1a67e80168d1
Autor:
Michael McCaul, David Tovey, Taryn Young, Vivian Welch, Omar Dewidar, Mireille Goetghebeur, Tamara Kredo, Andrea C. Tricco, Rebecca E. Glover, Janice Tufte, Amir Qaseem, Reveiz Ludovic, Rebecca L. Morgan, Per Olav Vandvik, Ivan D. Florez
Publikováno v:
Journal of Clinical Epidemiology. 151:88-95
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1850a96dfe4fdf59b1e151559bc5375d
https://doi.org/10.1016/j.jclinepi.2022.07.008
https://doi.org/10.1016/j.jclinepi.2022.07.008
Autor:
Rebecca E Glover, Nichola R Naylor
Publikováno v:
JAC-Antimicrobial Resistance. 5
Objectives The development of national action plans (NAPs) for antimicrobial resistance (AMR) has been promoted and supported by the WHO, with recent support in the form of costing and budgeting tools to aid in finance-allocation decisions within gov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abac8a3b6d74b2c9c0702316a68bf53b
https://doi.org/10.1093/jacamr/dlad064
https://doi.org/10.1093/jacamr/dlad064
Autor:
Mustafa Al-Haboubi, Rebecca E. Glover, Elizabeth Eastmure, Mark Petticrew, Nick Black, Nicholas Mays
Publikováno v:
Antibiotics, Vol 10, Iss 4, p 431 (2021)
Health surveillance systems are considered vital for combatting antimicrobial resistance (AMR); however, the evidence-base on the effectiveness of these systems in providing information that can be used by healthcare professionals, or the acceptabili
Externí odkaz:
https://doaj.org/article/f2452f2628384f84bacb99a6308f25b2
Publikováno v:
Critical Public Health. 33:197-206
Antimicrobial resistance (AMR) is often characterised as a ‘crisis’, requiring action by public, private, and third-sector stakeholders to achieve strategic change. Crisis narratives are powerful and may be co-opted to privilege solutions promote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f5c891bac5daa6c695ceed76478d7f9
https://doi.org/10.1080/09581596.2022.2026296
https://doi.org/10.1080/09581596.2022.2026296
Publikováno v:
The Lancet Microbe. 4:e2-e3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e74f18bf8815ecefb9ef6a23bde98c2b
https://doi.org/10.1016/s2666-5247(22)00235-x
https://doi.org/10.1016/s2666-5247(22)00235-x
Publikováno v:
BMJ (Clinical research ed.). 376
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6c889ae37d667b1c64449835e791f46
https://pubmed.ncbi.nlm.nih.gov/35197301
https://pubmed.ncbi.nlm.nih.gov/35197301